BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2015
View Archived Issues
CER-001 shows safety and efficacy in FHA patients
Read More
Agilvax and Humabs BioMed to develop targeted vaccines and immunotherapies
Read More
Teva and Eagle sign license for Eagle's bendamustine rapid infusion product
Read More
Stealth BioTherapeutics initiates clinical study of Bendavia for mitochondrial myopathy
Read More
Cytori initiates phase II cell therapy trial for knee osteoarthritis
Read More
ADS-5102 leads to significant improvements in levodopa-induced dyskinesia in phase II/III study
Read More
MST-188 enhances tPA thrombolytic effect
Read More
Resolaris receives EMA orphan drug designation for FSHD
Read More
Lonza and arGEN-X sign license agreement for GS Xceed antibody-production system
Read More
OncoSec Medical and Heat Biologics to evaluate combination of immunotherapy platforms
Read More
Lead Pharma to partner with Sanofi on treatments for autoimmune diseases
Read More
FDA expands indication for Revlimid in combination with dexamethasone
Read More
Merck KGaA discloses new fatty acid synthase inhibitors
Read More
Takeda patents TYK2 inhibitors
Read More
Israelian team reports throphoblast-derived microparticles
Read More
Medipure to develop first proprietary cannabinoid formulations
Read More
Esteve presents new sigma1 receptor ligands
Read More
Ergomed enters codevelopment agreement with Dilaforette for sevuparin in sickle cell disease
Read More
Janssen patent reports new RSV antivirals
Read More
Ocera Therapeutics releases preliminary phase IIa results on OCR-002 in cirrhosis patients
Read More
TB Alliance initiates phase I trial of next-generation nitroimidazole for TB
Read More
ReveraGenBioPharma initiates phase I trial of VBP-15 for Duchenne muscular dystrophy
Read More
FDA grants priority review to cobimetinib NDA
Read More
BMS seeks approval of additional indication for Eliquis in Japan
Read More
NGF implant therapy increases the levels of cholinergic markers in AD patients
Read More
AnGes changes marketing partner in Japan for HGF gene therapy
Read More